Glooko

By Jonah Comstock March 17, 2015
Diabetes management platform Glooko has raised $16.5 million in a round led by Canaan Partners. The round also included a strategic investment from Medtronic as well as funding from additional investors The Social+Capital Partnership and Samsung. Glooko began by making a cord that connected various glucometers to a user's smartphone. Over time, the company has moved from a connector chord to a...
By Jonah Comstock November 12, 2014
There's been a lot of talk lately about integrating activity data collected by devices like the Fitbit or the Misfit Shine into the clinical workflow, but there haven't been too many concrete examples yet. Now diabetes management technology company Glooko, which made its name with a universal cord and app for connecting glucometers to smartphones, is changing that. The company introduced a...
By Jonah Comstock October 2, 2014
Glooko, which makes a cable that syncs popular glucose meters to a companion app on smartphones, has always said it plans eventually to replace that cable with a wireless Bluetooth connection. Today, the company announced that they've finally released that product, the Bluetooth MeterSync Blue. The small box will plug into a patient's glucose meter and send the information wireless, via Bluetooth...
By Aditi Pai August 20, 2014
New York City-based medical device maker Philosys received FDA 510(k) clearance this week for its smartphone-connected glucose meter, Gmate Smart. To use the Gmate Smart glucometer, users launch the device's connected app, plug in their Gmate glucometer through the audio jack, insert a test strip into the glucometer, add a blood sample, and view results on the app. Gmate Smart's app is only...
By Brian Dolan June 24, 2014
On Friday the FDA issued a draft guidance document that revealed the agency intends to further deregulate medical device data systems (MDDS) and some medical image transfer systems. The FDA wrote that these types of devices are so low risk that they won't be regulating them at all. Examples of health software platforms that have class 1 medical device clearance as an MDDS includes Validic's...
By Jonah Comstock June 2, 2014
At the American Diabetes Association meeting next month, diabetes management software company Glooko and the Joslin Diabetes Center will launch HypoMap, a new patient-facing platform to help increase patients' awareness of hypoglycemic events. Hypoglycemic events are low blood sugar events associated with both Type 1 and Type 2 diabetes. Warning signs like sweatiness, shakiness, and weakness are...
By Brian Dolan March 5, 2014
Last week South Korea's health regulatory agency, the Ministry of Food and Drug Safety (MFDS), announced that it would review the latest version of Samsung's Galaxy phone -- the S5 -- to determine whether the device, which includes a built-in heart rate sensor -- should be regulated as a medical device. According to a local media report from Yonhap, the agency defines medical devices in a similar...
By Jonah Comstock February 20, 2014
Glooko has launched a new tool for its clinical partners, including the Scripps Health Whittier Diabetes Institute and the Joslin Diabetes Center. The Glooko Population Health Tracker is being announced next week at HIMSS in Orlando, but clinics and health plans have already begun using it. Palo Alto, California-based Glooko makes a MeterSync cable that connects Glooko's diabetes management app...
By Jonah Comstock February 5, 2014
The promise of Google's glucose-sensing contact lens is non-invasive continuous glucose monitoring: that rather than having to prick themselves with lancets several times a day, the nation's 26 million people with diabetes could take their readings on their phone via passively collected tears. If that sounds too good to be true to you, you're not alone. A number of voices in the diabetes care...
By Jonah Comstock January 21, 2014
Glooko, maker of diabetes management software and glucometer connector cables, is teaming up with the Joslin Diabetes Center to co-develop a "virtual Joslin" remote diabetes management platform to be offered to patients via private or government payors. "Right now patients with diabetes -- or members of health plans with diabetes -- cost the healthcare system anywhere from $7,000 a year to $21,...